Alterations in the gene expression profile of MCF-7 breast tumor cells in response to c-Jun
Janet Rinehart-Kim
Department of Microbiology and Molecular Cell Biology, Eastern Virginia Medical School, Norfolk, Virginia, USA
Search for more papers by this authorMelissa Johnston
Department of Microbiology and Molecular Cell Biology, Eastern Virginia Medical School, Norfolk, Virginia, USA
Search for more papers by this authorMichael Birrer
Medicine Branch, Division of Clinical Sciences, National Cancer Institute, NIH, Rockville, Maryland, USA
Search for more papers by this authorCorresponding Author
Timothy Bos
Department of Microbiology and Molecular Cell Biology, Eastern Virginia Medical School, Norfolk, Virginia, USA
Department of Microbiology and Molecular Cell Biology, Eastern Virginia Medical School, P.O. Box 1980, Norfolk, Virginia Fax: 757 624-2255Search for more papers by this authorJanet Rinehart-Kim
Department of Microbiology and Molecular Cell Biology, Eastern Virginia Medical School, Norfolk, Virginia, USA
Search for more papers by this authorMelissa Johnston
Department of Microbiology and Molecular Cell Biology, Eastern Virginia Medical School, Norfolk, Virginia, USA
Search for more papers by this authorMichael Birrer
Medicine Branch, Division of Clinical Sciences, National Cancer Institute, NIH, Rockville, Maryland, USA
Search for more papers by this authorCorresponding Author
Timothy Bos
Department of Microbiology and Molecular Cell Biology, Eastern Virginia Medical School, Norfolk, Virginia, USA
Department of Microbiology and Molecular Cell Biology, Eastern Virginia Medical School, P.O. Box 1980, Norfolk, Virginia Fax: 757 624-2255Search for more papers by this authorAbstract
MCF7 breast tumor cells overexpressing human c-Jun exhibit a transformed phenotype characterized not only by increased tumorigenicity but also by enhanced motility and invasion. The cellular phenotypic response to c-Jun overexpression is likely due, at least in part, to altered patterns of gene expression. In order to begin to understand the complexities by which elevated production of c-Jun alters the state of the cell, we have profiled the expression of 588 different genes by comparative hybridization. By using this approach, we have identified a total of 21 upregulated or downregulated gene targets responsive to c-Jun overexpression. Interestingly, 8 of these genes have been previously found associated with c-Jun or AP-1 activity and therefore provide internal validation for this approach to target gene discovery. The remaining 13 genes represent potential new c-Jun regulated target genes. Genomic sequence information was available for 15 of the 21 genes identified in this screen. Analysis of these genomic sequences revealed the presence of AP-1 or AP-1-like sequences in 12 of the 15 genes examined. Consistent with a direct mechanism of target regulation by c-Jun, gel shift analysis of selected AP-1-containing promoter regions revealed elevated and specific binding by proteins present in nuclear extracts of c-Jun expressing MCF7 cells. Int. J. Cancer 88:180–190, 2000. © 2000 Wiley-Liss, Inc.
REFERENCES
- Adler, V., Franklin, C.C. and Kraft, A.S., Phorbol esters stimulate the phosphorylation of c-Jun but not v-Jun: regulation by the N-terminal delta domain. Proc. nat. Acad. Sci. Wash., 89, 5341-5345 (1992a).
- Adler, V., Polotskaya, A., Wagner, F. and Kraft, A.S., Affinity-purified c-Jun amino-terminal protein kinase requires serine/threonine phosphorylation for activity. J. Biol. Chem., 267, 17001-17005 (1992b).
- Ainbinder, E., Bergelson, S., Pinkus, R. and Daniel, V., Regulatory mechanisms involved in activator-protein-1 (AP-1)-mediated activation of glutathione-S-transferase gene expression by chemical agents. Europ. J. Biochem., 243, 49-57 (1997).
- Araki, T. and Milbrandt, J., Ninjurin, a novel adhesion molecule, is induced by nerve injury and promotes axonal growth. Neuron, 17, 353-361 (1996).
- Araki, T., Zimonjic, D.B., Popescu, N.C. and Milbrandt, J., Mechanism of homophilic binding mediated by ninjurin, a novel widely expressed adhesion molecule. J. Biol. Chem., 272, 21373-21380 (1997).
- Bahr, M.J., Vincent, K.J., Arthur, M.J., Fowler, A.V., Smart, D.E., Wright, M.C., Clark, I.M., Benyon, R.C., Iredale, J.P. and Mann, D.A., Control of the tissue inhibitor of metalloproteinases-1 promoter in culture-activated rat hepatic stellate cells: regulation by activator protein-1 DNA binding proteins. Hepatology, 29, 839-848 (1999).
- Bellahcene, A. and Castronovo, V., Increased expression of osteonectin and osteopontin, 2 bone matrix proteins, in human breast cancer. Amer. J. Pathol., 146, 95-100 (1995).
- Biswas, C., Zhang, Y., DeCastro, R., Guo, H., Nakamura, T., Kataoka, H. and Nabeshima, K., The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res., 55, 434-439 (1995).
-
Bos, T.J.,
Margiotta, P.,
Bush, L. and
Wasilenko, W.,
Enhanced cell motility and invasion of chicken embryo fibroblasts in response to Jun over-expression.
Int. J. Cancer,
81,
404-410
(1999).
10.1002/(SICI)1097-0215(19990505)81:3<404::AID-IJC14>3.0.CO;2-I CAS PubMed Web of Science® Google Scholar
- Bos, T.J., Monteclaro, F.S., Mitsunobu, F., Ball, A.R. Jr., Chang, C.H., Nishimura, T. and Vogt, P.K., Efficient transformation of chicken embryo fibroblasts by c-Jun requires structural modification in coding and noncoding sequences. Genes Develop., 4, 1677-1687 (1990).
- Botelho, F.M., Edwards, D.R. and Richards, C.D., Oncostatin M stimulates c-Fos to bind a transcriptionally responsive AP- 1 element within the tissue inhibitor of metalloproteinase-1 promoter. J. Biol. Chem., 273, 5211-5218 (1998).
- Boyle, W.J., Smeal, T., Defize, L.H., Angel, P., Woodgett, J.R., Karin, M. and Hunter, T., Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity. Cell, 64, 573-584 (1991).
- Castellazzi, M., Dangy, J.-P., Mechta, F., Hirai, S.-I., Yaniv, M., Samarut, J., Lassailly, A. and Brun, G., Overexpression of avian or mouse c-jun in primary chick embryo fibroblasts confers a partially transformed phenotype. Oncogene, 5, 1541-1547 (1990).
- Edwards, D.R., Rocheleau, H., Sharma, R.R., Wills, A.J., Cowie, A., Hassell, J.A. and Heath, J.K., Involvement of AP1 and PEA3 binding sites in the regulation of murine tissue inhibitor of metalloproteinases-1 (TIMP-1) transcription. Biochim. Biophys. Acta, 1171, 41-55 (1992).
- Franklin, C.C., Unlap, T., Adler, V. and Kraft, A.S., Multiple signal transduction pathways mediate c-Jun protein phosphorylation. Cell Growth Differ., 4, 377-385 (1993).
- Gilles, C., Bassuk, J.A., Pulyaeva, H., Sage, E.H., Foidart, J.M. and Thompson, E.W., SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines. Cancer Res., 58, 5529-5536 (1998).
- Guyton, K.Z., Xu, Q. and Holbrook, N.J., Induction of the mammalian stress response gene GADD153 by oxidative stress: role of AP-1 element. Biochem. J., 314, 547-554 (1996).
- Hadman, M., Gabos, L., Loo, M., Sehgal, A. and Bos, T.J., Isolation and cloning of JTAP-1: a cathepsin like gene upregulated in response to V-Jun induced cell transformation. Oncogene, 12, 135-142 (1996).
- Hadman, M., Loo, M. and Bos, T.J., In vivo viral and cellular Jun complexes exhibit differential interaction with a number of in vitro generated 'AP-1- and CREB-like' target sequences. Oncogene, 8, 1895-1903 (1993).
- Hartl, M. and Vogt, P.K., Oncogenic transformation by Jun: role of transactivation and homodimerization. Cell Growth Differ., 3, 899-908 (1992).
- Jacob, K., Webber, M., Benayahu, D. and Kleinman, H.K., Osteonectin promotes prostate cancer cell migration and invasion: a possible mechanism for metastasis to bone. Cancer Res., 59, 4453-4457 (1999).
- Kardassis, D., Papakosta, P., Pardali, K. and Moustakas, A., c-Jun transactivates the promoter of the human p21(WAF1/Cip1) gene by acting as a superactivator of the ubiquitous transcription factor Sp1. J. Biol. Chem., 274, 29572-29581 (1999).
- Kerppola, T.K., Luk, D. and Curran, T., Fos is a preferential target of glucocorticoid receptor inhibition of AP-1 activity in vitro. Mol. Cell Biol., 13, 3782-3791 (1993).
- Kraemer, M., Tournaire, R., Dejong, V., Montreau, N., Briane, D., Derbin, C. and Binetruy, B., Rat embryo fibroblasts transformed by c-Jun display highly metastatic and angiogenic activities in vivo and deregulate gene expression of both angiogenic and antiangiogenic factors. Cell Growth Differ., 10, 193-200 (1999).
- Kumazaki, T. and Mitsui, Y., Alterations in transcription factor-binding activities to fibronectin promoter during aging of vascular endothelial cells. Mech. Ageing Develop., 88, 111-124 (1996).
- Kustikova, O., Kramerov, D., Grigorian, M., Berezin, V., Bock, E., Lukanidin, E. and Tulchinsky, E., Fra-1 induces morphological transformation and increases in vitro invasiveness and motility of epithelioid adenocarcinoma cells. Mol. Cell. Biol., 18, 7095-7105 (1998).
- Lamph, W.W., Wamsley, P., Sassone-Corsi, P. and Verma, I.M., Induction of proto-oncogene JUN/AP-1 by serum and TPA. Nature Lond., 334, 629-631 (1988).
- Lu, K.P., Hanes, S.D. and Hunter, T., A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature Lond., 380, 544-547 (1996).
- Ma, S., Rao, L., Freedberg, I.M. and Blumenberg, M., Transcriptional control of K5, K6, K14, and K17 keratin genes by AP-1 and NF-kappaB family members. Gene Expr., 6, 361-370 (1997).
- McBride, K. and Nemer, M., The C-terminal domain of c-fos is required for activation of an AP-1 site specific for jun-fos heterodimers. Mol. Cell. Biol., 18, 5073-5081 (1998).
- Mechta, F., Lallemand, D., Pfarr, C.M. and Yaniv, M., Transformation by ras modifies AP1 composition and activity. Oncogene, 14, 837-847 (1997).
- Mettouchi, A., Cabon, F., Montreau, N., Vernier, P., Mercier, G., Blangy, D., Tricoire, H., Vigie, P. and Binetruy, B., SPARC and thrombospondin genes are repressed by the c-jun oncogene in rat embryo fibroblasts. Embo J., 13, 5668-5678 (1994).
- Milon, L., Rousseau-Merck, M.F., Munier, A., Erent, M., Lascu, I., Capeau, J. and Lacombe, M.L., nm23-H4, a new member of the family of human nm23/nucleoside diphosphate kinase genes localised on chromosome 16p13. Hum. Genet., 99, 550-557 (1997).
- Miner, J.N. and Yamamoto, K.R., The basic region of AP-1 specifies glucocorticoid receptor activity at a composite response element. Genes Develop., 6, 2491-2501 (1992).
- Nicolaides, N.C., Correa, I., Casadevall, C., Travali, S., Soprano, K.J. and Calabretta, B., The Jun family members, c-Jun and JunD, transactivate the human c-myb promoter via an Ap1-like element. J. Biol. Chem., 267, 19665-19672 (1992).
- Olman, M.A., Hagood, J.S., Simmons, W.L., Fuller, G.M., Vinson, C. and White, K.E., Fibrin fragment induction of plasminogen activator inhibitor transcription is mediated by activator protein-1 through a highly conserved element. Blood, 94, 2029-2038 (1999).
- Philips, A., Teyssier, C., Galtier, F., Rivier-Covas, C., Rey, J.M., Rochefort, H. and Chalbos, D., FRA-1 expression level modulates regulation of activator protein-1 activity by estradiol in breast cancer cells. Mol. Endocrinol., 12, 973-985 (1998).
- Postel, E.H. NM23-NDP kinase. Int. J. Biochem. Cell. Biol., 30, 1291-1295 (1998).
- Pulverer, B.J., Hughes, K., Franklin, C.C., Kraft, A.S., Leevers, S.J. and Woodgett, J.R., Co-purification of mitogen-activated protein kinases with phorbol ester- induced c-Jun kinase activity in U937 leukaemic cells. Oncogene, 8, 407-415 (1993).
- Pulverer, B.J., Kyriakis, J.M., Avruch, J., Nikolakaki, E. and Woodgett, J.R., Phosphorylation of c-jun mediated by MAP kinases. Nature Lond., 353, 670-674 (1991).
- Ransone, L.J., Wamsley, P., Morley, K.L. and Verma, I.M., Domain swapping reveals the modular nature of Fos, Jun, and CREB proteins. Mol. Cell. Biol., 10, 4565-4573 (1990).
- Rittling, S.R., Coutinho, L., Amram, T. and Kolbe, M., AP-1/jun binding sites mediate serum inducibility of the human vimentin promoter. Nucleic Acids Res., 17, 1619-1633 (1989).
- Rossi, A., Jang, S.I., Ceci, R., Steinert, P.M. and Markova, N.G., Effect of AP1 transcription factors on the regulation of transcription in normal human epidermal keratinocytes. J Invest. Dermatol., 110, 34-40 (1998).
- Ryde, K. and Nathans, D., Induction of protooncogene c-jun by serum growth factors. Proc. nat. Acad. Sci. Wash., 85, 8464-8467 (1988).
- Schreiber, M., Kolbus, A., Piu, F., Szabowski, A., Mohle-Steinlein, U., Tian, J., Karin, M., Angel, P. and Wagner, E.F., Control of cell cycle progression by c-Jun is p53 dependent. Genes Develop., 13, 607-619 (1999).
- Schule, R., Rangarajan, P., Kliewer, S., Ransone, L.J., Bolado, J., Yang, N., Verma, I.M. and Evans, R.M., Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell, 62, 1217-1226 (1990).
- Schutte, J., Minna, J.D. and Birrer, M.J., Deregulated expression of human c-jun transforms primary rat embryo cells in cooperation with an activated c-Ha-ras gene and transforms rat- 1a cells as a single gene. Proc. nat. Acad. Sci. Wash., 86, 2257-2261 (1989).
- Smeal, T., Binetruy, B., Mercola, D., Grover-Bardwick, A., Heidecker, G., Rapp, U.R. and Karin, M., Oncoprotein-mediated signalling cascade stimulates c-Jun activity by phosphorylation of serines 63 and 73. Mol. Cell. Biol., 12, 3507-3513 (1992).
- Smeal, T., Binetruy, B., Mercola, D.A., Birrer, M. and Karin, M., Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73. Nature Lond., 354, 494-6 (1991).
- Smith, L.M., Wise, S.C., Hendricks, D.T., Sabichi, A.L., Bos, T., Reddy, P., Brown, P.H. and Birrer, M.J., cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype. Oncogene, 18, 6063-6070 (1999).
- Sommers, C.L., Skerker, J.M., Chrysogelos, S.A., Bosseler, M. and Gelmann, E.P., Regulation of vimentin gene transcription in human breast cancer cell lines. Cell Growth Differ., 5, 839-846 (1994).
- Touray, M., Ryan, F., Jaggi, R. and Martin, F., Characterisation of functional inhibition of the glucocorticoid receptor by Fos/Jun. Oncogene, 6, 1227-1234 (1991).
- Ubeda, M., Vallejo, M. and Habener, J.F., CHOP enhancement of gene transcription by interactions with Jun/Fos AP- 1 complex proteins. Mol. Cell. Biol., 19, 7589-7599 (1999).
- Vogt, P.K. and Bos, T.J., jun: oncogene and transcription factor. Adv. Cancer Res., 55, 1-35 (1990).
- Wolfgang, C.D., Chen, B.P., Martindale, J.L., Holbrook, N.J. and Hai, T., gadd153/Chop10, a potential target gene of the transcriptional repressor ATF3. Mol Cell Biol, 17, 6700-6707 (1997).
- Wong, W.Y., Havarstein, L.S., Morgan, I.M. and Vogt, P.K., c-Jun causes focus formation and anchorage-independent growth in culture but is non-tumorigenic. Oncogene, 7, 2077-2080 (1992).
- Yang-Yen, H.F., Chambard, J.C., Sun, Y.L., Smeal, T., Schmidt, T.J., Drouin, J. and Karin, M., Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein- protein interaction. Cell, 62, 1205-1215 (1990).
- Yi, J. and Beckerle, M.C., The human TRIP6 gene encodes a LIM domain protein and maps to chromosome 7q22, a region associated with tumorigenesis. Genomics, 49, 314-316 (1998).
- Yoshioka, K., Deng, T., Cavigelli, M. and Karin, M., Antitumor promotion by phenolic antioxidants: inhibition of AP-1 activity through induction of Fra expression. Proc. Nat. Acad. Sci. Wash., 92, 4972-4976 (1995).
- Zumbrunn, J. and Trueb, B., A zyxin-related protein whose synthesis is reduced in virally transformed fibroblasts. Eur. J. Biochem., 241, 657-663 (1996).